KEYMED BIO-B: VOLUNTARY ANNOUNCEMENTNEW DRUG APPLICATION OF STAPOKIBART INJECTION FORTHE TREATMENT OF CHRONIC RHINOSINUSITIS WITH NASAL POLYPSACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.